Sandbox:Marufa Marium: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
Von Willebrand’s Disease(vWD) was first discovered by Erik Adolf von Willebrand, a Finnish Physician, in 1926, in a Swedish-language article “Hereditär pseudohemofili” ("Hereditary pseudohemophilia") after assessing a 5 year-old Finnish Girl and 66 members of her family from 1924-1926. In 1957, decreased level of a plasma factor ‘ Factor ⅷ later called ‘Von Willebrand factor’ were first identified in the pathogenesis of Von Willebrand’s Disease. In early 1970s Ristocetin was used to diagnose vWD after inducing platelet aggregation. Later immunoprecipitation techniques were used to understand vWD and it’s varieties. | Von Willebrand’s Disease(vWD) was first discovered by Erik Adolf von Willebrand, a Finnish Physician, in 1926, in a Swedish-language article “Hereditär pseudohemofili” ("Hereditary pseudohemophilia") after assessing a 5 year-old Finnish Girl and 66 members of her family from 1924-1926. In 1957, decreased level of a plasma factor ‘ Factor ⅷ later called ‘Von Willebrand factor’ were first identified in the pathogenesis of Von Willebrand’s Disease. In early 1970s Ristocetin was used to diagnose vWD after inducing platelet aggregation. Later immunoprecipitation techniques were used to understand vWD and it’s varieties. | ||
==Classification== | ==Classification== | ||
[[vWD]] may be classified according to [[Hereditary]] and [[Aquired]] causes. | [[vWD]] may be classified according to [[Hereditary]] and [[Aquired]] causes.<ref name="CappellePans2016">{{cite journal|last1=Cappelle|first1=Sarah|last2=Pans|first2=Steven|last3=Sciot|first3=Raf|title=Imaging features of chondromyxoid fibroma: report of 15 cases and literature review|journal=The British Journal of Radiology|volume=89|issue=1064|year=2016|pages=20160088|issn=0007-1285|doi=10.1259/bjr.20160088}}</ref> | ||
[[vWD]] is sub-classified according to [[Hereditary]] in four types. | [[vWD]] is sub-classified according to [[Hereditary]] in four types. | ||
*Type 1 | *Type 1 | ||
| Line 12: | Line 12: | ||
*Type 3 | *Type 3 | ||
*Pseudo or platelet-type | *Pseudo or platelet-type | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 14:46, 4 September 2020
Overview
Von Willebrand’s Disease:
Historical Perspective
Von Willebrand’s Disease(vWD) was first discovered by Erik Adolf von Willebrand, a Finnish Physician, in 1926, in a Swedish-language article “Hereditär pseudohemofili” ("Hereditary pseudohemophilia") after assessing a 5 year-old Finnish Girl and 66 members of her family from 1924-1926. In 1957, decreased level of a plasma factor ‘ Factor ⅷ later called ‘Von Willebrand factor’ were first identified in the pathogenesis of Von Willebrand’s Disease. In early 1970s Ristocetin was used to diagnose vWD after inducing platelet aggregation. Later immunoprecipitation techniques were used to understand vWD and it’s varieties.
Classification
vWD may be classified according to Hereditary and Aquired causes.[1] vWD is sub-classified according to Hereditary in four types.
- Type 1
- Type 2: Type 2 is further divided into 4 subtypes: 2A, 2B, 2M, 2N
- Type 3
- Pseudo or platelet-type
References
- ↑ Cappelle, Sarah; Pans, Steven; Sciot, Raf (2016). "Imaging features of chondromyxoid fibroma: report of 15 cases and literature review". The British Journal of Radiology. 89 (1064): 20160088. doi:10.1259/bjr.20160088. ISSN 0007-1285.